GranuFlo® and NaturaLyte® FDA Warnings
GranuFlo® and NaturaLyte® are chemicals used in kidney dialysis machines. These chemicals have been linked to a condition called metabolic alkalosis, which can lead to serious health problems, such as cardiac arrest, reduced blood oxygen levels, low blood pressure, and even sudden cardiac death.
At Ferrer, Poirot & Wansbrough, we believe that negligent companies like Fresenius Medical Care should be held responsible for the medical bills and pain and suffering of people who were injured by their products. If you or someone you love was injured by GranuFlo or NaturaLyte while receiving kidney dialysis, call us today at (800) 210-8503 or fill out a free initial consultation form.
On July 14, 2012, The New York Times published an article about the U.S. Food and Drug Administration’s (FDA) investigation of kidney dialysis centers operated by Fresenius Medical Care. After reviewing the safety of the products, the FDA issued a Class I Recall for GranuFlo and NaturaLyte on March 29, 2012.
GranuFlo and NaturaLyte injuries indicated in the FDA recall can be life-threatening and may require long periods of hospitalization and expensive treatments. Let Ferrer, Poirot & Wansbrough help you get the compensation you deserve for your medical expenses.
Our GranuFlo® Lawyers Can Help
When you’re sick or injured, you don’t want to face a legal claim. At Ferrer, Poirot & Wansbrough, our GranuFlo injury lawyers can handle your claim for you while you focus on getting better. We’ve helped countless drug injury victims move forward with their lives—now let us help you.
GranuFlo® and NaturaLyte® are registered trademarks of Fresenius Medical Care North America.
This law firm is not associated with, sponsored by, or affiliated with The New York Times, the U.S. Food and Drug Administration, or Fresenius Medical Care.